Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Location status: Recruiting
NCT Number: NCT04922762
The purpose of this research study is to examine the effect of various forms of exercise training on blood vessel function in healthy individuals as well as individuals with mental health disorders (posttraumatic stress disorder (PTSD) and/or generalized anxiety disorder (GAD)).
Interested in participating?
Request Info18 year–35 year
All sexes
Interventional
Not applicable
Richmond, Virginia, 23298, United States
Location status: Recruiting
Study #2 is made up of five sessions done on five separate days and the entire study can be completed in as little as 14 weeks. All testing sessions will take place at the Exercise Physiology Research Laboratory. Volunteers will be asked to participate in one initial testing session (Visit 1) lasting < 1 hour that will help make them more familiar with the study equipment and procedures, determine body measures (height, weight, body fat), determine the maximum strength of their forearm and calf, and require one blood draw. The following two testing sessions (Visits 2 and 3) with each session lasting between 2-3 hours that will involve multiple tests designed to determine the health of their blood vessels. For Visit #2 they will be randomly given either antioxidant pills or placebo pills to determine the effect of oxidants on blood vessel health. For Visit #3, they will be given whatever set of pills (antioxidant or placebo) that they did not receive during Visit #2. also include two additional testing days (Visits 5 and 6) that are identical to Visits #2 and #3, two visits to test endurance or strength prior to and after the exercise training (Visit 4 and 7), and ten weeks of exercise training (done 3-5 days per week). The exercise training will include one of three treadmill running programs that differ by exercise intensity and/or exercise frequency.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Week 1 3 days/week for 20 minutes/day Performed at 70% of heart rate maximum
Week 2 3 days/week for 30 minutes/day Performed at 70% of heart rate maximum
Weeks 3-10 3 days/week for 45 minutes/day Performed at 70% of heart rate maximum
Week 1 3 days/week for 31 minutes/day 10 minute warm up at 50% of heart rate maximum 2 x 4 minute intervals 4 minutes at 90-95% of heart rate maximum 3 minutes at 70% of heart rate maximum REPEAT 7 minute cool down at 50% of heart rate maximum
Week 2 3 days/week for 38 minutes/day 10 minute warm up at 50% of heart rate maximum 3 x 4 minute intervals 4 minutes at 90-95% of heart rate maximum 3 minutes at 70% of heart rate maximum REPEAT 2 TIMES 7minute cool down at 50% of heart rate maximum
Weeks 3-10 3 days/week for 45 minutes/day 10 minute warm up at 50% of heart rate maximum 4 x 4 minute intervals 4 minutes at 90-95% of heart rate maximum 3 minutes at 70% of heart rate maximum REPEAT 3 TIMES 7 minute cool down at 50% of heart rate maximum
Week 1 5 days/week for 20 minutes/day Performed at 70% of heart rate maximum
Week 2 5 days/week for 30 minutes/day Performed at 70% of heart rate maximum
Weeks 3-10 5 days/week for 45 minutes/day Performed at 70% of heart rate maximum
Time frame: Baseline to the end of the final visit, about 14 weeks
Change in Brachial Artery Dilation from Baseline Values
Time frame: Baseline to the end of the final visit, about 14 weeks
Change in Leg Blood Flow Values from Baseline
Time frame: Baseline to the end of the final visit, about 14 weeks
Change in Brachial Artery Dilation from Baseline Values
Contact information is provided by the study sponsor or research team.
Virginia Commonwealth University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04916327
Cardiovascular Diseases, Mental Disorders
Richmond, Virginia, United States
View Trial DetailsNCT04916340
Cardiovascular Diseases, Mental Disorders
Richmond, Virginia, United States
View Trial DetailsNCT06626646
Arterial Occlusive Diseases, Arteriosclerosis
North York, Ontario, Canada
View Trial DetailsNCT03898570
Arterial Occlusive Diseases, Arteriosclerosis
Palo Alto, California, United States
View Trial Details